health canada approval zepbound tirzepatide obesity canada date has approved the first sleep apnea drug for adults with Zepbound, Obesity Version of Eli

P.Zuzarte-LusV.CassadoA.et al (2019)

As weve discussed, semaglutide and similar drugs can modulate gut motility in ways that sometimes align favourably with IBS (e.g

For patients with diabetes, high blood glucose levels and being overweight translates to greater risk of developing complications

For instance, in June 2024, a recent study by the National Library of Medicine, Secular Trends in Diabetes in India (STRiDE-I), revealed a concerning rise in type 2 diabetes (T2DM) prevalence among younger individuals (ages 2039) in southern India

Tirzepatide Outperforms Dulaglutide on Cardiorenal Outcomes in High-Risk Diabetes Pearl Steinzor Maggie L